ICE
59
-3
HSIC
54
-3
HCP
58
4
AXP
66
2
JNPR
46
3
CINF
47
2
ABT
57
-5
BBY
40
3
HOG
29
-4
NAVI
41
-3
USB
50
2
CAH
47
3
LLY
39
9
INTC
35
-2
BMY
53
-7
FOXA
55
9
HD
47
-5
ED
48
3
SYK
64
-4
MAS
51
4
ICE
59
-3
HSIC
54
-3
HCP
58
4
AXP
66
2
JNPR
46
3
CINF
47
2
ABT
57
-5
BBY
40
3
HOG
29
-4
NAVI
41
-3
USB
50
2
CAH
47
3
LLY
39
9
INTC
35
-2
BMY
53
-7
FOXA
55
9
HD
47
-5
ED
48
3
SYK
64
-4
MAS
51
4
Financhill
Back

Sage Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22

SAGE
Sage Therapeutics

Last Price:
4.83
Seasonality Move:
10.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Sage Therapeutics Price Quote

$4.83
-0.08 (-1.63%)
(Updated: November 21, 2024 at 1:50 PM ET)

Sage Therapeutics Key Stats

Sell
22
Sage Therapeutics (SAGE) is a Sell
Day range:
$4.62 - $5.13
52-week range:
$4.74 - $28.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.72
P/B ratio:
0.53%
Volume:
1.6M
Avg. volume:
789.3K
1-year change:
-75.1%
Market cap:
$292.4M
Revenue:
$86.5M
EPS:
$-5.57

How Much Does Sage Therapeutics Make?

Is Sage Therapeutics Growing As A Company?

  • What Is Sage Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 3.37%
  • What Is Sage Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Sage Therapeutics Stock Price Performance

  • Did Sage Therapeutics Stock Go Up Last Month?
    Sage Therapeutics share price went down by -35.14% last month
  • Did SAGE's Share Price Rise Over The Last Year?
    SAGE share price fell by -75.1% over the past 1 year

What Is Sage Therapeutics 52-Week High & Low?

Sage Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sage Therapeutics?

  • How Much Debt Does Sage Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Sage Therapeutics Have?
    Cash and short term investments quarterly total is $569.2M
  • What Is Sage Therapeutics’s Book Value Per Share?
    Book value per share is 9.02

Is Sage Therapeutics Cash Flow Positive?

  • What Is SAGE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$320.2M
  • What Is Sage Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10.4M
  • What Is Sage Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $262.2M

Sage Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    SAGE return on invested capital is -48.2%
  • What Is Sage Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -43.07%
  • What Is SAGE Return On Equity?
    ROE is a measure of profitability and is -48.2%

Sage Therapeutics Earnings Date & Stock Price

Sage Therapeutics Competitors

  • Who Are Sage Therapeutics's Competitors?
    Below is a list of companies who compete with Sage Therapeutics or are related in some way:
    • Biogen Inc (BIIB)
    • Johnson & Johnson (JNJ)
    • Lifecore Biomedical Inc (LFCR)
    • Organon & Co (OGN)
    • Outset Medical Inc (OM)

Sage Therapeutics Dividend Yield

Sage Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 1.32%
Revenue: 337.08% 9.37%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 16
Sell Recommendations: 0
Price Target: 10.00
Upside from Last Price: 103.67%

Major Shareholders

  • How many SAGE shares are owned by institutional investors?
    104.2M SAGE shares are owned by institutional investors
  • How many SAGE shares are owned by insiders?
    1.2M SAGE shares are owned by insiders